“In November 2022, a study revealed that blood pressure drugs that stimulate type 2 and 4 angiotensin II receptors in the brain were associated with lower rates of dementia among new users of ...

Semaglutide — the active ingredient in type 2 diabetes and weight-loss glucagon-like peptide-1 agonist ( GLP-1) medications Ozempic and Wegovy — may help lower dementia risk, a new study finds.

GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...

New study suggests that Novo Nordisk’s Ozempic may lower dementia risk and nicotine use. Meanwhile, UnitedHealth Group’s cyberattack woes aren’t over yet.

Ozempic was also linked to a greater reduction in Alzheimer’s risk compared with metformin and several other older diabetes drugs. Brain health benefits of Ozempic didn’t change based on ...

READ MORE: Ozempic and Wegovy may reduce dementia risk, study suggests ; ... Mice treated with the drug showed a 62 percent reduction in tau tangles compared to the untreated mice.

has found that its “miracle” weight loss drug used for diabetes, Ozempic, is linked to a significant reduction in the risk of dementia and other cognitive issues. What Happened: A study ...

Health . What Ozempic Does to Your Brain: It May Reduce the Risk of Dementia 48 percent . Odds are you've heard of GLP-1 drugs like Ozempic for managing type 2 diabetes and shedding pounds.

A study finds a drug known for weight loss may also help to reduce dementia. The study looked at semaglutide, the scientific name for Novo Nordisk's (NVO) (DK:NOVO.B) Ozempic, with the intent of ...

GLP-1 drugs may reduce asthma symptoms in obese adults, offering a steroid-free alternative to treatment. The study includes ...